期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺癌药物治疗的疗效预测

Research of predicting the outcome of treatment for lung cancer
原文传递
导出
摘要 近年来,肺癌的药物治疗进展迅速,细胞毒药物更新换代,靶向药物层出不穷.大量的临床数据证实,肺癌的药物治疗存在个体化差异,而这种差异,主要和药物的基因组学相关,利用药物基因组学实行对肺癌的个体化治疗,已成为肺癌转化性研究的热点.文章讨论了与肺癌药物治疗敏感性有关的主要分子标志物.
作者 卓莹 吴一龙
机构地区 [
出处 《肿瘤研究与临床》 CAS 2007年第7期-,共4页 Cancer Research and Clinic
关键词 敏感性 基因多态性 癌 非小细胞肺 靶向治疗
分类号 R734 [医药卫生—肿瘤]
  • 相关文献

参考文献38

  • 1Rosell R,Cobo M,Isla D. Applications of genomics in NSCLC[J].Lung Cancer,2005,(z2):S33-S40.doi:10.1016/S0169-5002(05)81571-5.
  • 2林莉,刘晓晴,宋三泰.肺癌常用化疗药物相关的抗药标志研究进展[J].现代肿瘤医学,2006,14(3):352-354. 被引量：5
  • 3Gautam A,Bepler G. Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase[J].Cancer Research,2006,(13):6497-6502.doi:10.1158/0008-5472.CAN-05-4462.
  • 4Bepler G,Sharma S,Cantor A. RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer[J].Journal of Clinical Oncology,2004,(10):1878-1885.doi:10.1200/JCO.2004.12.002.
  • 5Bepler G,Kusmartseva I,Sharma S. RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer[J].Journal of Clinical Oncology,2006,(29):4731-4737.doi:10.1200/JCO.2006.06.1101.
  • 6Taron M,Rosell R,Felip E. BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer[J].Hum Mol Genet Genet,2004,(20):2443-2449.
  • 7Quinn JE,Kennedy RD,Mullan PB. BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis[J].CANCER RESEARCH,2003,(19):6221-6228.
  • 8Csiki I,Yanagisawa K,Haruki N. Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer[J].Cancer Research,2006,(01):143-150.doi:10.1158/0008-5472.CAN-05-1357.
  • 9Arnold NB,Ketterer K,Kleeff J. Thioredoxin is downstream of Smad 7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer[J].Cancer Research,2004,(10):3599-3606.doi:10.1158/0008-5472.CAN-03-2999.
  • 10Oda Y,Ohishi Y,Saito T. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase Ⅱ alpha expression,and with poor prognosis in synovial sarcoma[J].Journal of Pathology,2003,(02):251-258.

二级参考文献14

  • 1Rosell R.Predicting response to Paclitaxol/Carboplatin -based therapy in NSCLC[J].Seminars in oncology,2002,28(4suppl 14):37～44.
  • 2Rosell R.Pharmacogenomic research and serum DNA analysis in the treatment of non-smsll cell lung cancer[J].Rev Oncologia,2001,38:60～71.
  • 3Kumagai A,Dunphy WG.Purification and molecular cloning of Plx1,a Cdc25-regulatory Kinase from Xenopus egg extracts[J].Science,1996,273(6):1377～1380.
  • 4Rosell R.Determinants of response and resistance of cytotoxics[J].Semin Oncol,2002,291 suppl(4):110～118.
  • 5Hou SM,Ryk C,Kannio A,et al.Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors[J].Environ Mol Mutagen,2003,41(1):37～42.
  • 6Hu Z,Wei Q,Wang X,et al.DNA repair gene XPD polymorphism and lung cancer risk:a meta-analysis[J].Lung Cancer,2004,46(1):1～10.
  • 7HDavid J,Park,Stoehlmacher J,et al.A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum -based chemotherapy in patients with advanced colorectal cancer[J].Cancer Research,2001,15:8654～8658.
  • 8Camps C,Sarries C,Roig B.Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients[J].Clin Lung Cancer,2003,4(4):237～241.
  • 9Rosell R,Crino L,Danenberg K.Targeted therapy in combination with gemcitabine in non-small cell lung cancer[J].Semin Oncol,2003,30(4 Suppl 10):19～25.
  • 10Rosell R,Taron M,Barnadas A,et al.Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer[J].Cancer Control,2003,10(4):297～305.

共引文献8

肿瘤研究与临床
2007年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部